A gene therapy designed to enhance the anticancer immune response in dogs and cats, showing effectiveness in treating breast cancer and melanoma by altering the tumor microenvironment and reducing chronic inflammation.

Curelab Veterinary partners with veterinary clinics for clinical research on cancer, osteoarthritis, inflammatory bowel disease, and chronic dermatitis, offering the latest therapy for inclusion in cutting-edge studies.